veracellLV

Data marketplace

Study Marketplace

Acquire access to existing biological studies or commission new experimental data.

Request a bespoke study

Define the biological system, perturbations, and quantitative readouts you need. Our network of vetted wet labs will bid to complete the study.

Request study

Exclusive Studies

Request exclusive ownership or nonexclusive access to an individual study.

6 studies

Study 1

T3 + TRH dose response

RNA-seq
Treatment arms
4
Design
Single agents + combinations

T3 + TRH combination • 3 dose levels + vehicle • longitudinal sampling • bulk RNA-seq

Time course
Days 1, 3, 5 and 7
Deliverables
Bulk RNA-seq (FASTQ + count matrices)
Exclusive study
Request study

Study 2

Farnesol and olanzapine screen

IHC
Treatment arms
6
Design
Single-agent dose response

Farnesol + olanzapine • multiple dose levels • longitudinal sampling • quantitative IHC/IF

Time course
Days 0, 1, 3, 5 and 7
Deliverables
Quantitative IHC/IF protein-marker staining
Exclusive study
Request study

Study 3

Doxycycline and naltrexone screen

IHC
Treatment arms
8
Design
Single-agent dose response

Doxycycline + naltrexone • multiple dose levels • longitudinal sampling • quantitative IHC/IF

Time course
Days 0, 1, 3, 5 and 7
Deliverables
Quantitative IHC/IF protein-marker staining
Exclusive study
Request study

Study 4

RSPO pathway RNA-seq and IHC/IF panel

RNA-seq + IHC
Treatment arms
6
Design
Single agents + combinations

RSPO2, RSPO4, RSPO2:4 + WAY-316606 • single-dose RNA-seq arms • quantitative IHC/IF

Time course
Days 0–1 RNA-seq QC; IHC/IF collection through Day 7
Deliverables
Bulk RNA-seq + quantitative IHC/IF protein-marker staining
Exclusive study
Request study

Study 5

Farnesol + doxycycline combination

RNA-seq + IHC
Treatment arms
4
Design
Single agents + combinations

Farnesol + doxycycline • single agents + combination • longitudinal sampling • split RNA-seq/IHC

Time course
Days 0, 1, 3, 5 and 7
Deliverables
Bulk RNA-seq + quantitative IHC/IF protein-marker staining
Exclusive study
Request study

Study 6

Olanzapine + naltrexone combination

RNA-seq
Treatment arms
4
Design
Single agents + combinations

Olanzapine + naltrexone • single agents + combination • longitudinal sampling • bulk RNA-seq

Time course
Days 0, 1, 3 and 5
Deliverables
Bulk RNA-seq (FASTQ + count matrices) with RIN QC
Exclusive study
Request study

Concentrations marked TBC are not included in the current study metadata.